Immunosuppression with Antitumour Necrosis Factor Therapy Leading to Strongyloides Hyperinfection Syndrome

Case Reports in Infectious Diseases
Muhammad Farhan KhaliqJames Perry

Abstract

Strongyloides stercoralis is an endemic parasitic infection that can remain asymptomatic for years, but it can cause death in immunosuppressed individuals. Here, we present a case of Strongyloides hyperinfection in a 75-year-old male secondary to sepsis and chronic immunosuppression due to TNF-α inhibitors. Despite aggressive treatment including broad-spectrum antibiotics and antihelminths, his respiratory failure worsened and he died after palliative extubation. S. stercoralis infection remains a diagnostic challenge. Presentation with Strongyloides is often nonspecific, and eosinophilia is absent in hyperinfection. Diagnosis can be delayed, especially in low-prevalence areas where suspicion is low. Strongyloides should be considered in the differential diagnosis in the presence of risk factors including immunosuppressive therapy, and a travel history should be carefully obtained. Patients with recurrent enterobacterial sepsis or respiratory failure with diffuse infiltrates in the setting of eosinophilia should undergo testing for Strongyloides. A multidisciplinary approach can result in earlier diagnosis and favorable outcomes.

References

Aug 1, 1990·American Journal of Epidemiology·T W GyorkosJ D MacLean
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A A Siddiqui, S L Berk
Jan 17, 2004·Clinical Microbiology Reviews·Paul B Keiser, Thomas B Nutman
Sep 1, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sue LimKevin C Kain
Apr 9, 2005·Arthritis and Rheumatism·M David Boatright, Benjamin W E Wang
Mar 12, 2009·Current Opinion in Pulmonary Medicine·Vannan Kandi Vijayan
Feb 23, 2010·Journal of the American Academy of Dermatology·Amy BasileNoah Craft
Aug 25, 2010·Current Opinion in Infectious Diseases·Martin MontesNicolas Barros
Feb 19, 2011·Journal of the National Medical Association·Bobby KakatiFarshad Aduli
May 3, 2011·Emerging Infectious Diseases·Virginie PrendkiOlivier Bouchaud
Dec 26, 2012·Pathogens and Global Health·Linda NabhaIrini Sereti
Feb 12, 2013·BMC Infectious Diseases·Dora BuonfrateZeno Bisoffi
May 16, 2013·PLoS Neglected Tropical Diseases·Zeno BisoffiMarco Albonico
Jul 23, 2013·PLoS Neglected Tropical Diseases·Fabian SchärPeter Odermatt
Jan 16, 2014·PLoS Neglected Tropical Diseases·Zeno BisoffiThomas B Nutman
Jul 28, 2017·The American Journal of Tropical Medicine and Hygiene·Ana Requena-MéndezJosé Muñoz

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar
lavage
biopsies
ELISA

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.